Antidepressant-like activity of Bezafibrate in mice models of depression: a behavioral and neurobiological characterization
BackgroundDepression represents a major global public health challenge, inflicting profound suffering on patients while imposing substantial socioeconomic burdens on families and healthcare systems. Although monoamine-based antidepressants remain first-line pharmacotherapy, accumulating clinical evi...
Saved in:
| Main Authors: | Dawei Xu, Jin Zhou, Siyi Zhou, Weizhen Wang, Chengniu Wang, Bo Jiang, Wei Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1595341/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increases in mitochondrial biogenesis impair carcinogenesis at multiple levels
by: Xiao Wang, et al.
Published: (2011-10-01) -
Metabolic effects of bezafibrate in mitochondrial disease
by: Hannah Steele, et al.
Published: (2020-02-01) -
The effects of a semen cuscutae flavonoids-based antidepressant treatment on microbiome and metabolome in mice
by: Qianfeng Shao, et al.
Published: (2025-05-01) -
Engineered Genetic Circuits Activated by Bezafibrate Improve ESC‐Based TAA Cancer Vaccine Efficacy and PD‐L1 Nanobody Therapy
by: Meiling Jin, et al.
Published: (2025-06-01) -
Bezafibrate-driven mitochondrial targeting enhances antitumor immunity and prevents lung cancer via CD8+ T cell infiltration and MDSC reduction
by: Jing Pan, et al.
Published: (2025-04-01)